Item 7.01 Regulation FD Disclosure

On September 9, 2022, Moleculin Biotech, Inc. (the "Company") is using the attached presentation for its participation in the 2nd Annual Marie Sklodowska-Curie Symposium on Cancer Research and Care and is set forth as Exhibit 99.1 herein. The information contained in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, is being furnished and shall not be "filed" for the purpose of the Securities Exchange Act of 1934, as amended ("Exchange Act"), nor shall it be incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended ("Securities Act"), unless specifically identified therein as being incorporated by reference.

Item 9.01 Financial Statements and Exhibits.





(d) Exhibits.



Exhibit No. Description



99.1   Presentation dated September 2022

104 Cover page Interactive Data File (formatted as Inline XBRL document)

© Edgar Online, source Glimpses